This funding round will reportedly provide 30Med with the resources needed to further develop its platform and expand its reach within the medical community.

Founded in 2023 by Ayman Ragab, 30Med operates in the B2B space, aiming to bridge the gap between pharmaceutical companies and physicians.

The company leverages interactive videos and conference events to showcase new medicines and facilitate continuous learning for medical professionals.

According to the company’s website, 30Med boasts a user base of over 2,000 doctors actively engaged with the platform, seeking to stay updated on the latest advancements in medicine and pharmaceuticals.

“This funding is a strong validation of our mission,” said Dr. Ayman Ragab, CEO of 30Med. “It allows us to accelerate our efforts in transforming medical education.”

The press release highlights 30Med’s existing partnerships with pharmaceutical companies in Egypt, underlining the startup’s commitment to reshaping the medical education landscape within the country.